We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01836029
Recruitment Status : Unknown
Verified January 2016 by VentiRx Pharmaceuticals Inc..
Recruitment status was:  Active, not recruiting
First Posted : April 19, 2013
Last Update Posted : January 7, 2016
Information provided by (Responsible Party):
VentiRx Pharmaceuticals Inc.